0001209191-20-036787.txt : 20200615 0001209191-20-036787.hdr.sgml : 20200615 20200615191300 ACCESSION NUMBER: 0001209191-20-036787 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200611 FILED AS OF DATE: 20200615 DATE AS OF CHANGE: 20200615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Watkins Thomas CENTRAL INDEX KEY: 0001307935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34186 FILM NUMBER: 20964575 MAIL ADDRESS: STREET 1: 1221 GULF SHORE BLVD N #303 CITY: NAPLES STATE: FL ZIP: 34102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001347178 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030491827 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 BUSINESS PHONE: 202-734-3400 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-11 0 0001347178 Vanda Pharmaceuticals Inc. VNDA 0001307935 Watkins Thomas 1221 GULF SHORE BLVD N #303 NAPLES FL 34102 1 0 0 0 Common Stock 2020-06-11 4 A 0 5000 0.00 A 40323 D Stock Option (Right to Buy) 10.57 2020-06-11 4 A 0 10000 0.00 A 2030-06-10 Common Stock 10000 10000 D Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. This option vests and becomes exercisable with respect to 100% of the option shares on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. /s/ H. Thomas Watkins 2020-06-15